| Financial Year |
March 31 2023 |
| Monetary Funds |
78,462,217.14 |
| Held-for-trading Financial Assets |
40,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
23,330,126.47 |
| Advances to Suppliers |
404,775.67 |
| Other Receivables |
710,328.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,016,889.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
241,375.83 |
| Total Current Assets |
154,165,713.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
16,698,747.67 |
| Investment Properties |
107,434,200.81 |
| Fixed Assetes |
225,413,220.76 |
| Under-construction Projects |
8,125,706.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,337,633.40 |
| R&D expenses |
-- |
| Goodwill |
40,359,271.98 |
| Long-Term Deferred and Prepaid Expenses |
10,461,489.83 |
| Deferred Income Tax Assets |
13,483,565.10 |
| Other Non-Current Assets |
6,015,137.45 |
| Sub-Total of Non-Current Assets |
454,924,587.22 |
| Total Assets |
609,090,300.26 |
| Short-Term Loans |
53,059,111.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,566,191.05 |
| Accounts Payable |
96,871,840.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,185,978.25 |
| Taxes Payable |
6,452,818.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,167,264.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,842,785.28 |
| Other Current Liabilities |
32,229.13 |
| Sub-Total of Current Liabilities |
203,595,165.74 |
| Long-term Loans |
32,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,619,576.88 |
| Other Non-Current Liabilities |
120,713,127.93 |
| Sub-Total of Non-Current Liabilities |
163,037,253.75 |
| Total Liabilities |
366,632,419.49 |
| Paid-In Capital(Or Share Stock) |
380,160,000.00 |
| Capital Surplus |
59,598,588.49 |
| Surplus Reserve |
41,708,798.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-322,792,719.08 |
| Minority Stockholder's Interest |
83,783,212.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
158,674,668.09 |
| Owner's Equity（Stockholder's Equity） |
242,457,880.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
609,090,300.26 |
